Each issue of Cancer strives to be comprehensive, spanning the breadth of oncology disciplines and providing something for everyone involved in cancer research, risk reduction, treatment, and patient care. 主要研究方向:医学-ONCOLOGY 肿瘤学 CARCINOGENESIS《癌变》 国际标准刊号:ISSN 0143-3334;EISSN1460-...
Simon Jean-PierreVan Belle,VéroniqueCocquyt, inCritical Reviews in Oncology/Hematology, 2003 The goals ofcancer treatmentare to eliminate disease or, in the absence of disease eradication, to prolong the patient's life and to palliate symptoms. Although survival is the most important outcome, the...
The article offers information on the cancer review consultation for a 58-year-old woman who has completed primary treatment for cancer. It explores the key role of the general practitioner in giving support and information throughout the illness while complementing the interventions of other medical...
Personal details of any patient must only be included in your article or in any supplementary materials (including all images and videos) in cases where written permission has been given by the patient (or, where applicable, the next of kin). We advise you to review Elsevier’s policy on ...
Functional CRISPR screens in patient-matched pre-treatment and post-treatment glioblastoma models identify the PTP4A–ROBO1 axis as a driver of tumorigenicity and enriched ROBO1 expression in recurrent glioblastoma that can be targeted with CAR T cell therapy. Chirayu R. Chokshi , Muhammad Vaseem ...
Rates of psychiatric conditions common to end-stage cancer patients (delirium, depression, anxiety disorders) remain unchanged. However, patient numbers have increased as the population has aged; indeed, cancer is a chief cause of mortality and morbidity
Patient liability represented up to 21.6% of care costs and increased over the period 1992–2003 for most stage and treatment categories, even when care costs decreased or remained unchanged. The greatest monthly patient liability was incurred by chemo-radiotherapy patients, which ranged from $1617 ...
The role of patient-derived ovarian cancer organoids in the study of PARP inhibitors sensitivity and resistance: from genomic analysis to functional testing Epithelial ovarian cancer (EOC) harbors distinct genetic features such as homologous recombination repair (HRR) deficiency, and therefore may respo...
Aspirin as a possible treatment of cancer has been of increasing interest for over 50 years, but the balance of the risks and benefits remains a point of contention. We summarise the valid published evidence ‘for’ and ‘against’ the use of aspirin as
Several complementary technologies can be used to explore the immune contexture of tumours, and to derive biomarkers that could enable the adaptation of individual treatment approaches for each patient, as well as monitoring a response to anticancer therapies....